[Use of PET for staging, treatment evaluation, and follow-up in esophageal cancers]. / Apport de la TEP au diagnostic, évaluation thérapeutique et suivi du cancer de l'oesophage.
Cancer Radiother
; 12(6-7): 633-9, 2008 Nov.
Article
en Fr
| MEDLINE
| ID: mdl-18693057
ABSTRACT
FDG-(18F) PET can now be usually included in the treatment strategy of esophageal cancers for the pretreatment staging in operable tumours or for the diagnosis of recurrence. PET is also a good tool in conformal radiation therapy for improving the target coverage to treat the metabolic target volume or the biological target volume. Furthermore, PET seems to be interesting for evaluation of tumour response and could modify the treatment strategy after neoadjuvant chemotherapy or concurrent chemotherapy and radiation therapy. New radiotracers could allow advances in biological and molecular tumour delineation and contribute to change in treatment strategy based on functional and biological imaging.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Esofágicas
/
Radioterapia Conformacional
/
Tomografía de Emisión de Positrones
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
Fr
Revista:
Cancer Radiother
Asunto de la revista:
NEOPLASIAS
/
RADIOTERAPIA
Año:
2008
Tipo del documento:
Article
País de afiliación:
Francia